Rhythm Pharmaceuticals, Inc. (RYTM)
103.97
-0.74
(-0.71%)
USD |
NASDAQ |
Sep 14, 11:00
Rhythm Pharmaceuticals 1 Year Total Returns (Daily) : 6.93% for Sept. 11, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 11, 2026 | 6.93% |
| September 10, 2026 | 1.92% |
| September 09, 2026 | -0.37% |
| September 08, 2026 | 2.03% |
| September 04, 2026 | -1.75% |
| September 03, 2026 | 3.15% |
| September 02, 2026 | 1.16% |
| September 01, 2026 | 1.54% |
| August 31, 2026 | 2.89% |
| August 28, 2026 | 2.82% |
| August 27, 2026 | 10.00% |
| August 26, 2026 | 10.54% |
| August 25, 2026 | 14.26% |
| August 24, 2026 | 7.91% |
| August 21, 2026 | 8.18% |
| August 20, 2026 | 10.35% |
| August 19, 2026 | 19.08% |
| August 18, 2026 | 17.49% |
| August 17, 2026 | 18.27% |
| August 14, 2026 | 19.69% |
| August 13, 2026 | 18.56% |
| August 12, 2026 | 21.92% |
| August 11, 2026 | 19.65% |
| August 10, 2026 | 25.55% |
| August 07, 2026 | 25.03% |
| Date | Value |
|---|---|
| August 06, 2026 | 24.54% |
| August 05, 2026 | 25.00% |
| August 04, 2026 | 17.22% |
| August 03, 2026 | 16.40% |
| July 31, 2026 | 16.45% |
| July 30, 2026 | 24.90% |
| July 29, 2026 | 24.41% |
| July 28, 2026 | 26.10% |
| July 27, 2026 | 22.76% |
| July 24, 2026 | 16.99% |
| July 23, 2026 | 16.91% |
| July 22, 2026 | 18.39% |
| July 21, 2026 | 20.28% |
| July 20, 2026 | 17.26% |
| July 17, 2026 | 17.56% |
| July 16, 2026 | 16.02% |
| July 15, 2026 | 22.75% |
| July 14, 2026 | 23.34% |
| July 13, 2026 | 23.98% |
| July 10, 2026 | 21.74% |
| July 09, 2026 | 29.75% |
| July 08, 2026 | 75.67% |
| July 07, 2026 | 72.41% |
| July 06, 2026 | 69.80% |
| July 02, 2026 | 70.61% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 15.00% |
| Alnylam Pharmaceuticals, Inc. | -46.93% |
| BioMarin Pharmaceutical, Inc. | 17.47% |
| Cytokinetics, Inc. | 38.35% |
| Exelixis, Inc. | 43.64% |